tirzepatide slows gastric emptying More than 1 in 4 adults with obesity had a novel physiologic subtype marked by fast emptying, discordantly low postmeal GLP‑1 levels, and increased postmeal hunger. In a retrospective analysis, participants Tirzepatide for Weight Loss &

+ The calculations use standard pharmaceutical formulas: concentration (mg/mL) = vial size water volume, and draw volume (mL) = target dose concentration

65 However, a controlled, randomized, double-blind, multicenter study assessing the safety, tolerability, pharmacokinetics, and efficacy of nidufexor in patients with MASH was terminated without results posted (NCT02913105)

All methodologies and procedures strictly adhered to the guidelines and standards outlined in the Recommendations for Evaluation and Analysis of Disproportionality in the Use of Safety Signal Detection Based on Individual Case Safety Reports (READUS-PV) (Li et al., 2025b)

This broader mechanism may explain why retatrutide has shown especially strong weight loss results in early trials, though semaglutide currently has the advantage of regulatory approval and longer-term real-world data